
4DMT Announces Positive Phase 2 PRISM Interim Results for Intravitreal 4D-150 in a Broad Wet AMD Population Affirming Favorable Safety Profile and ...
EMERYVILLE, Calif., July 17, 2024 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading clinical-stage genetic medicines company focused on unlocking the full...

AMD to Report Fiscal Second Quarter 2024 Financial Results
SANTA CLARA, Calif., July 16, 2024 (GLOBE NEWSWIRE) -- AMD (NASDAQ: AMD) announced today that it will report fiscal second quarter 2024 financial results on Tuesday, July 30, 2024, after the close ...

Is AMD Stock a Buy Now?
AMD just announced its intent to purchase an AI software company. It still lags Nvidia significantly in the AI chip race.

Can the Silo AI Acquisition Change AMD's Fate, or Is It a Risky Bet?
Although AMD's acquisition of Silo AI expands the AI ecosystem, growing fundamental challenges, including stiff competition from NVIDIA, make the stock a risky bet.

What AMD, Nvidia, and TSM Stock Investors Should Know About Recent Semiconductor Updates
Semiconductor investors are patiently waiting for Taiwan Semiconductor Manufacturing to report earnings next week.

AMD plans to acquire Silo AI in $665 million deal
Advanced Micro Devices (AMD) is getting a lift following news of the semiconductor maker's plans to acquire Finnish artificial intelligence company Silo AI. Josh Lipton and Julie Hyman discuss AMD'...

AMD Expands Its Reach by Buying Silo AI, Europe's Largest Private AI Lab
Shares of Advanced Micro Devices (AMD) rose nearly 4% Wednesday after the chipmaker said it is buying the largest private artificial intelligence (AI) lab in Europe to expand its reach in the market.

Nvidia's Blackwell Launch Can Lift These 2 Chip Stocks. AMD Is Still a Winner.
The maker of graphics processing units for artificial intelligence will benefit from both higher sales volume and higher prices when its next chips become available, KeyBanc says.

Outlook Therapeutics® Announces UK MHRA Marketing Authorization of LYTENAVA™ (bevacizumab gamma) for the Treatment of Wet AMD
ISELIN, N.J., July 08, 2024 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on development and commercialization of ONS-5010/LYTENAVA™ (bevacizuma...

Nvidia and AMD Could Help This Stock-Split ETF Turn $200,000 Into $1 Million
Nvidia makes the most powerful data center chips for developing artificial intelligence (AI) models. The AI industry is expanding, and a number of other chip companies are creating value from the t...

3 Overvalued Tech Stocks Heading for a Fall
When it comes to stocks, valuation matters. The price-to-earnings (P/E) ratio measures a company's share price relative to its earnings per share (EPS).

AMD's Key Advantage Over Intel Is Set to Vanish
Intel has fallen behind TSMC in manufacturing, enabling AMD to tap into superior manufacturing technology. Intel is using TSMC for its upcoming Lunar Lake chips, and its Intel 18A process should cl...

AMD Might Not Beat Nvidia, but Here's Why It's Still a Long-Term Buy
A supply-constrained Nvidia provides AMD with an auspicious entry point into the boundless AI GPU market. AMD's aggressive strategy in response to the AI chip supply gap will bear fruit over time.

Better Chip Stock: AMD vs. Micron
AMD and Micron both faced tough macro and cyclical headwinds. Both companies are overcoming those challenges.

Is Advanced Micro Devices (AMD) Stock a Buy?
AI is boosting AMD's business despite dramatically lagging Nvidia. Revenue growth should accelerate as AMD's AI businesses grow.
Related Companies